Last Updated on January 6, 2024 by The Health Master
The Indian Pharmaceutical Alliance (IPA) is all set to host the seventh edition of the “Global Pharmaceutical Quality Summit (GPQS),” from 24th to 25th February, 2022 virtually.
The theme for this year is “Making quality pharmaceuticals in India, sustainably, for the World.” The forum aims to bring manufacturers and regulators on a common platform to facilitate discussions resulting in meaningful and actionable outcomes in quality.
The summit will feature more than 30 global leaders and regulators taking part in 15 sessions covering key aspects of manufacturing and quality with a view on sustainability, IPA notified via a statement.
The conference will commence with a keynote address by S. Aparna, Secretary, Department of Pharmaceuticals (DoP), and a special address by Dr. V. G. Somani, Drugs Controller General of India (DCGI).
The two-day summit will include technical sessions, panel discussions and special addresses by global subject matter experts on topics such as quality excellence in pharmaceuticals operations, vaccine development, and learnings on quality excellence from other industries, among others.
The concluding session will have a CEO panel discussion from leading Indian pharma companies such as Cadila, Cipla, Dr Reddy’s, Lupin, Sun Pharma and Torrent Pharma to deliberate on ‘Sustainable end-to-end operations and Quality Excellence,’ the statement added.
It also said that the key regulators attending the summit are:
- Dr VG Somani, DCG(I);
- Dr Rogério Gaspar, Director, Regulation and Prequalification Department, WHO;
- Dr Manisha Shridhar, Regional Advisor, WHO – SEARO;
- Dr Douglas Throckmorton, Deputy Director for Regulatory Platforms, US FDA;
- Kristan Callahan, International Relations Specialist, US FDA India Office;
- Dr Sotirios Paraschos, Inspector, Certification of Substances Department, EDQM.
The Forum is expected to witness participation from more than 1,000 registered participants, and invitees from CDSCO, media, senior leadership, WHO India Office, USFDA India Office, IGBA, PDA, USP, OPPI, IDMA, academia, and the IPA Executive Council.
The knowledge partner for the summit is McKinsey & Company and collaborators are Invest India, USP and PDA, concluded the statement.
The mandatory QR codes on APIs
NPPA fixes retail price of 19 formulations: February 2022
ICMR to conduct Clinical Trial for new drugs regimen for MDR TB
PCB issues directions to Pharma Companies to comply with norms
Police protection sought for Drugs Control Officers
USFDA gives nod to Lupin for sNDA for Solosec
India reports outbreak of H5N1 Bird Flu Virus
USFDA gives nod to this Molecule to treat retinal vascular diseases
Govt recommends continuation of anti-dumping duty on import of Amoxycillin
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
